Next Thursday, the Virginia Board of Health will make it clear whether women’s health care is actually a priority for the Commonwealth, or if the abortion industry is going to be singled out from basic health and safety standards. Make no mistake: most of the suggested changes are an attempt to water down the standards.
For example, one of the primary goals of the abortion industry is to differentiate between surgical abortions and so-called “medication” abortions (i.e. chemical abortions). The industry claims that with “medication” abortions, all they do is “write a prescription,” but that is far from the truth. They want to differentiate because they claim that some abortion centers do “only medication” abortions and therefore shouldn’t be held to the same health and safety standards as those that do surgical abortions.
In fact, with a “medication” abortion (often referred to as RU-486), the patient takes only the first of two regimen of the drug at the abortion center. The patient then takes the second regimen of the drug at a later point, sometimes self-administered at home. If the drugs are not administered according to FDA guidelines, “medication” abortions can have a higher failure rate, which then require a surgical abortion to complete the taking of the unborn child’s life. And it is common, if not standard operating procedures, for abortion centers to administer RU-486 outside of FDA guidelines; therefore, complications are not uncommon, some of which can be life threatening.
Proving that point, according to inspection reports at the Virginia Women’s Wellness Center in Virginia Beach, it was discovered that for 36.6 percent of patients that had medication abortions in January 2014, a repeat medication dose or a surgical procedure was required to complete the abortion. According to the FDA, RU-486 is only to be used until 49 days gestation and if used according to FDA guidelines has an 8 percent failure rate. The farther along in gestation a woman is, the more likely it is that RU-486 will fail. According to the New England Journal of Medicine, statistics indicate that there is a 17 percent failure rate at 50-55 days, and a 23 percent failure rate at 57-63 days. Virginia Women's Wellness' rate of 36.6 percent failure is over four times the average. Its plan to correct the problem: “These cases will no longer be documented in the complication log.”
Of course, when you have to do both types of an abortion on the same patient, the abortion center profits even more.
The abortion industry’s answer: water down the health and safety standards.
According to statements made in government documents, there is one abortion center in Virginia – Planned Parenthood’s Blacksburg facility right near Virginia Tech – which performs only medication abortions. However, on it’s website, the abortion center says, “During the abortion pill (medication abortion) visit, you must agree — before you start — that you will have an in-clinic abortion if the abortion pill does not work.”
The question is, does the “medication abortion only” facility do the “in-clinic” abortion (surgical) at the Blacksburg facility or send the patient to an abortion center in another city? That facility reported only 73 abortions last year. Where those medication or surgical? If surgical, why are they claiming to only do medication?
Oh, and don’t be fooled into thinking that the abortion industry cares that the health and safety standards are high for surgical abortions. In fact, during the review process of the standards, one doctor who performs abortions but was part of a “physicians panel” put together by the Department of Health said, “First trimester abortions are not really surgery.”
That’s the kind of expert testimony the Department of Health is relying on to make the changes.